Karin Strandberg

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex
    Pallonji Bhiladvala
    Department of Cardiology, Lund University, Malmo University Hospital, Sweden
    Thromb Res 118:213-9. 2006
  2. ncbi Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity
    Karin Strandberg
    Department of Clinical Chemistry, Lund University, Malmo University Hospital, SE 205 02 Malmo, Sweden
    Thromb Res 121:145-51. 2007
  3. ncbi Activated protein C-protein C inhibitor complex in patients with abdominal aortic aneurysms: is it associated with diameter and growth rate?
    Tilo Kölbel
    Department of Vascular Diseases, Malmo University Hospital, Sweden
    Vasc Endovascular Surg 42:135-40. 2008
  4. ncbi Coagulation activation and ultrasound characteristics in patients with carotid artery disease
    Tilo Kölbel
    Vascular Center, Malmo University Hospital, Malmo, Sweden
    Thromb Res 125:171-7. 2010
  5. ncbi Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms
    Tilo Kölbel
    Department of Vascular Diseases, Malmo University Hospital, Malmo, Sweden
    J Vasc Surg 43:935-9. 2006
  6. ncbi Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children
    Olof Rask
    Department of Paediatrics, Malmo University Hospital, Malmo, Sweden
    Cardiol Young 19:152-8. 2009
  7. ncbi The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis
    Johan L Elf
    Department of Emergency Medicine, Lund University, Lund University Hospital, Lund, Sweden
    J Thromb Thrombolysis 29:465-70. 2010
  8. ncbi The APC-PCI complex concentration predicts outcome of aortic surgery
    Gunnar Nilsson
    Department of Anaesthesiology and Intensive Care, Lund University, Malmo University Hospital, SE 205 02 Malmo, Sweden
    Thromb Res 120:237-44. 2007
  9. ncbi Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients
    Omran Bakoush
    Department of Nephrologyy, University Hospital, Lund, Sweden
    Nephron Clin Pract 110:c151-7. 2008
  10. ncbi Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin
    Mattias Wieloch
    Department of Cardiology, Malmo University Hospital, Malmo, Sweden
    Thromb Res 124:344-8. 2009

Collaborators

Detail Information

Publications15

  1. ncbi Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex
    Pallonji Bhiladvala
    Department of Cardiology, Lund University, Malmo University Hospital, Sweden
    Thromb Res 118:213-9. 2006
    ..We have evaluated a newly devised immunofluorimetric assay for measuring plasma concentration of APC-PCI complexes among patients with suspected acute coronary syndrome...
  2. ncbi Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity
    Karin Strandberg
    Department of Clinical Chemistry, Lund University, Malmo University Hospital, SE 205 02 Malmo, Sweden
    Thromb Res 121:145-51. 2007
    ....
  3. ncbi Activated protein C-protein C inhibitor complex in patients with abdominal aortic aneurysms: is it associated with diameter and growth rate?
    Tilo Kölbel
    Department of Vascular Diseases, Malmo University Hospital, Sweden
    Vasc Endovascular Surg 42:135-40. 2008
    ..11-0.31; P < or = .001). APC-PCI correlated with AAA diameter (r = .22; P = .001), body mass index (r = -.19; P = .004), and age (r = .19; P = .004). APC-PCI did not correlate with AAA growth rate (r = .11; P = .14)...
  4. ncbi Coagulation activation and ultrasound characteristics in patients with carotid artery disease
    Tilo Kölbel
    Vascular Center, Malmo University Hospital, Malmo, Sweden
    Thromb Res 125:171-7. 2010
    ....
  5. ncbi Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms
    Tilo Kölbel
    Department of Vascular Diseases, Malmo University Hospital, Malmo, Sweden
    J Vasc Surg 43:935-9. 2006
    ..We studied whether it can provide information useful for the diagnosis and treatment of arterial vascular disease...
  6. ncbi Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children
    Olof Rask
    Department of Paediatrics, Malmo University Hospital, Malmo, Sweden
    Cardiol Young 19:152-8. 2009
    ....
  7. ncbi The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis
    Johan L Elf
    Department of Emergency Medicine, Lund University, Lund University Hospital, Lund, Sweden
    J Thromb Thrombolysis 29:465-70. 2010
    ..However, for the exclusion of DVT at the pre-specified cut-off level, the APC-PCI complex perform inferior to the D-dimer assays in this study...
  8. ncbi The APC-PCI complex concentration predicts outcome of aortic surgery
    Gunnar Nilsson
    Department of Anaesthesiology and Intensive Care, Lund University, Malmo University Hospital, SE 205 02 Malmo, Sweden
    Thromb Res 120:237-44. 2007
    ..The purpose of the study was to establish whether the APC-PCI complex can provide information useful for the assessment of outcome after aortic surgery...
  9. ncbi Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients
    Omran Bakoush
    Department of Nephrologyy, University Hospital, Lund, Sweden
    Nephron Clin Pract 110:c151-7. 2008
    ..The plasma concentration of the complex between APC and PCI (P-APC-PCI complex) is increased in hypercoagulable states and is therefore a sensitive indicator of the degree of activation of blood coagulation...
  10. ncbi Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin
    Mattias Wieloch
    Department of Cardiology, Malmo University Hospital, Malmo, Sweden
    Thromb Res 124:344-8. 2009
    ..The purpose of this study was to compare and evaluate INR values obtained by the point-of-care device CoaguChek XS, to Owren PT in a hospital setting...
  11. ncbi Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity
    Karin Strandberg
    Department of Coagulation Disorders, Lund University, , Sweden
    Clin Appl Thromb Hemost 12:61-7. 2006
    ....
  12. ncbi [ADAMTS13--actor and marker in thrombotic microangiopathy]
    Jens Peter Gøtze
    Klinisk Biokemisk Afdeling, Rigshospitalet, Kopenhamn, Denmark
    Lakartidningen 105:1092-5. 2008
  13. ncbi [New marker in thrombotic thrombocytopenic purpura]
    Jens Peter Gøtze
    Rigshospitalet, Klinisk Biokemisk Afdeling, Københavns Universitet, Biomedicinsk Institut, København Ø
    Ugeskr Laeger 170:2446-9. 2008
    ..Measurement of ADAMTS-13 activity is useful for the diagnosis of TTP and may also be relevant as a prognostic test for recurrent TTP...
  14. ncbi No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency
    Carla Y Vossen
    Department of Pathology, University of Vermont, Burlington, Vermont 05405, USA
    Blood Coagul Fibrinolysis 15:573-6. 2004
    ..Thus, carriers of the prothrombin G20210A mutation do not have increased protein C activation despite the increased thrombin generation resulting from the higher prothrombin concentrations associated with the G20210A mutation...
  15. ncbi Stabilyte tubes that contain strongly acidic citrate prevent in vitro complex formation between activated protein C and protein C inhibitor
    Karin Strandberg
    Thromb Haemost 89:947-9. 2003